China Antiretroviral Treatment Adherence for Life

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
HIV Infections
Interventions
BEHAVIORAL

Electronic drug monitoring feedback data

All patients were given electronic drug monitors that can monitor pill-taking behavior. In the intervention arm, patients and their attending doctors were given the electronic drug monitoring data on pill bottle openings at each monthly visit for use in adherence counseling sessions. Control arm patients were not given their electronic drug monitoring feedback data and their counseling sessions were based on self-reported adherence, as per standard of care in Dali.

Trial Locations (1)

Unknown

Dali Second People's Hospital, Dali

All Listed Sponsors
collaborator

Beijing Ditan Hospital

OTHER

collaborator

Second People's Hospital, Dali

OTHER

lead

Boston University

OTHER

NCT00661258 - China Antiretroviral Treatment Adherence for Life | Biotech Hunter | Biotech Hunter